Concepedia

Institution (Healthcare)

LungenClinic Grosshansdorf

HomepageROR

Also Known As

LungenClinic Grosshansdorf

3.3K

Publications

415.5K

Citations

170

Authors

460

Concepts

About

LungenClinic Grosshansdorf is a healthcare institution in Großhansdorf, Germany known for medicine, oncology, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

91

682

62.8K

2

Health Sciences

44

158

25.8K

3

Engineering

15

22

639

4

Business

1

1

19

5

Education

1

5

195

LungenClinic Grosshansdorf

×

3.3K

Publications

415.5K

Citations

YearCitations

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson,

New England Journal of Medicine

2016

9.8K

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Paul Baas,

New England Journal of Medicine

2015

8.4K

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo,

New England Journal of Medicine

2018

3.7K

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański,

New England Journal of Medicine

2018

3.1K

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabé,

New England Journal of Medicine

2019

2.8K

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Silvia Novello, Fabrice Barlési, Raffaele Califano,

Annals of Oncology

2016

2.6K

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Giuseppe Giaccone, Roy S. Herbst, Christian Manegold,

Journal of Clinical Oncology

2004

1.7K

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson,

Journal of Clinical Oncology

2019

1.6K

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

Martin Reck, Joachim von Pawel, Petr Zatloukal,

Journal of Clinical Oncology

2009

1.5K

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna,

The Lancet

2009

1.4K

Page 1